Nat. Biotechnol. 29, 471–472 (2011); published online 7 June 2011; corrected after print 7 February 2012
In the version of this article originally published, in Table 1, Sinovac Biotech was described as having been acquired by Novartis in March. Novartis acquired a different company, Tianyuan, as stated later in the article.
Additional information
The online version of the original article can be found at 10.1038/nbt0611-471
Rights and permissions
About this article
Cite this article
Jia, H., Carey, K. Correction: Corrigendum: Chinese vaccine developers gain WHO imprimatur. Nat Biotechnol 30, 193 (2012). https://doi.org/10.1038/nbt0212-193e
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0212-193e
